---
layout: post
title: 'Predicting the HPV P16 Status of Oropharyngeal Cancer Patients Using Radiomics and an Ensemble of Random Forests'
date: 2017-11-26
tags: paper
categories: papers
tabs: true
image: rsna2017_predictinghpv.jpeg-srcw.jpg
---

## Predicting the HPV P16 Status of Oropharyngeal Cancer Patients Using Radiomics and an Ensemble of Random Forests
**Elhalawani, H., Mohamed, A., Volpe, V., Yang, P., Campbell, S., Granberry, R., Ger, R., Fave, X., Zhang, L., Marai, GE, Vock, DM, Canahuate, GM, Macking, D., Court, L., Gunn, GB, Rao, A., Fuller, CD**
- PDF: [rsna2017_predictinghpv.pdf](/documents/rsna2017_predictinghpv.pdf)

[![image](/images/rsna2017_predictinghpv.jpeg-srcw.jpg){:style="max-width: 100%"}](/images/rsna2017_predictinghpv.jpeg-srcw.jpg)
- Caption: Flowchart of patient selection for inclusion.

Recent data demonstrate that human papillomavirus (HPV)-associated oropharyngeal cancers (OPC) have discrete biology and clinical behavior as compared to HPV-negative OPC. We hypothesize that some phenotypic image features can be correlated to tumor biology in a non-invasive fashion. Some imaging features, specifically shape and intensity features can make a distinction between HPV-associated and HPV-negative OPC. Quantitative information from pretreatment imaging of intact tumor can give a better idea on tumor biology. Further studies are needed to validate the correlation between these radiomic biomarkers and other intrinsic tumor characteristics.<br><br>
<strong>Support:</strong><br>
National Institutes of Health:<br>
NCI-R01-CA214825, &ldquo;SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer Treatment&rdquo;<br>
NCI-R01CA225190, &ldquo;QuBBD: Precision E â€“Radiomics for Dynamic Big Head & Neck Cancer Data&rdquo;
